SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001193125-16-727701
Filing Date
2016-09-30
Accepted
2016-09-30 16:58:08
Documents
13

Document Format Files

Seq Description Document Type Size
1 REVISED PRELIMINARY PROXY PERTAINING TO A MERGER d201065dprer14a.htm PRER14A 3457943
2 GRAPHIC g201065001.jpg GRAPHIC 47508
3 GRAPHIC g201065002.jpg GRAPHIC 37016
4 GRAPHIC g201065g02a82.jpg GRAPHIC 45210
5 GRAPHIC g201065g10f31.jpg GRAPHIC 54045
6 GRAPHIC g201065g11f40.jpg GRAPHIC 50369
7 GRAPHIC g201065g23s39.jpg GRAPHIC 39779
8 GRAPHIC g201065g42s45.jpg GRAPHIC 21001
9 GRAPHIC g201065g46f91.jpg GRAPHIC 42485
10 GRAPHIC g201065g50r73.jpg GRAPHIC 34280
11 GRAPHIC g201065g56w12.jpg GRAPHIC 82001
12 GRAPHIC g201065new004.jpg GRAPHIC 33879
13 GRAPHIC g201065stm257.jpg GRAPHIC 23140
  Complete submission text file 0001193125-16-727701.txt   4163521
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-36830 | Film No.: 161913439
SIC: 2834 Pharmaceutical Preparations